Literature DB >> 10654671

Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons.

H Sawada1, S Shimohama.   

Abstract

There is a gender difference, or male predominance, in Parkinson's disease and attention deficit hyperactivity disorder (ADHD). Although the reason why it is predominantly the male who suffers from the diseases is still unknown, the female steroid hormone may be involved in the pathogenesis. Estrogen is a female sex hormone with a steroid structure. Like other steroid hormones, it binds to specific receptors in the nuclei and regulates gene transcription (genomic effects). In addition to the genomic effects, it can act as an antioxidant, a process not mediated by the estrogen receptor (nongenomic effects). Further, estrogen can have a novel action through a specific receptor located in the plasma membrane. In the central nervous system, estrogen provides neuroprotection mediated through multiple mechanisms. In this article, we review several possible mechanisms for the neuroprotective effects including antiapoptotic protection by estrogens as transcription factors, protection against oxidative stress by estrogens acting as antioxidants, and neurotrophic cross talk through the signal cascade shared with neurotrophic factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10654671     DOI: 10.1016/s0149-7634(99)00059-7

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  17 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

2.  Neurobiological Underpinnings of the Estrogen - Mood Relationship.

Authors:  Whitney Wharton; Carey E Gleason; Sandra R M S Olson; Cynthia M Carlsson; Sanjay Asthana
Journal:  Curr Psychiatry Rev       Date:  2012-08-01

3.  Gender and the Parkinson's disease phenotype.

Authors:  Yasuhiko Baba; John D Putzke; Nathaniel R Whaley; Zbigniew K Wszolek; Ryan J Uitti
Journal:  J Neurol       Date:  2005-09-12       Impact factor: 4.849

4.  Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Authors:  Andrea Tamás; Andrea Lubics; István Lengvári; Dóra Reglodi
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 5.  A compensatory role for declarative memory in neurodevelopmental disorders.

Authors:  Michael T Ullman; Mariel Y Pullman
Journal:  Neurosci Biobehav Rev       Date:  2015-01-15       Impact factor: 8.989

6.  Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory.

Authors:  C Leranth; R H Roth; J D Elsworth; F Naftolin; T L Horvath; D E Redmond
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

7.  Experimental study on the protective effect of puerarin to Parkinson disease.

Authors:  Xueli Li; Shenggang Sun; E'tang Tong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

8.  Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.

Authors:  Whitney Wharton; Carey E Gleason; Katelin R Lorenze; Tamara S Markgraf; Michele L Ries; Cynthia M Carlsson; Sanjay Asthana
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

Review 9.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  Estradiol attenuates programmed cell death after stroke-like injury.

Authors:  Shane W Rau; Dena B Dubal; Martina Böttner; Lynnette M Gerhold; Phyllis M Wise
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.